Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-12
2000-06-06
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 63, 514185, 514410, A01N 4336
Patent
active
060719443
ABSTRACT:
The present invention in general terms includes a method of treating cancerous cells containing a pigment, the method including irradiation of the cells with light of comprising the steps: (1) subjecting the cancerous cells to relatively high power light so as to substantially reduce the amount of the pigment in the cells; (2) treating the cancerous cells with one or more photosensitizing agent; followed by (3) subjecting the cancerous cells to relatively low power light so as to activate the photosensitizing agent(s).
REFERENCES:
Sarna et al., "Photosensitizaiton of Melanins: A comparative Study", Photochemistry and Photobiology vol. 42, No. 5, pp. 529-532, 1985.
Database CAPLUS on STN, No. 1996:168613, Young et al., "Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative." Arch. Opthalmol. (Chicago). Abstract, 1996 114(2), pp. 186-192.
Database BIOSIS on STN, No. 1993:255603, Gonzales et al., "Photodynamic Therapy of Pigmented Choroidal Melanomas" Investigtive Opthalmology & Visual Science. Abstract, 1995, 36(5), pp. 871-878.
Dougherty, T.J. (1987) Photosensitizers: therapy and detection of malignant tumours. Photochem. Photobiol., 45, 879-889.
Boyle R. W. and D. David (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64, 469-485.
Marcus S. (1996) Clinical photodynamic therapy; the continuing evolution. In Photodynamic therapy: basic principles and clinical application. Marcel Dekker New York (Edited by Henderson B. W. and Dougherty T. J.) pp 219-268.
Biolo. R., G. Jori, M. Soncin, R. Pratesi, U. Vanni, B. Rihter, M.E. Kenney and M. A. J. Rodgers (1994) Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphathalocyanine. Photochem. Photobiol. 59, 362-365.
Biolo. R., G. Jori, M. Soncin, B. Rihter, M.E. Kenney and M. A. J. Rodgers (1996) Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice. Photochem. Photobiol. 63, 224-228.
Sounik J. R., L. A. Schechtman, B. D. Rihther, W. E. Ford, M.A.J. Rodgers and M. E. Kenney (1990) Synthesis and characterization of naphthalocyanines and phthalocyanines of use in sensitizer studies. In Photodynamic Therapy: Mechanisms II, SPIE vol. 1203 (Edited by T. J. Dougherty and A.Katzir), pp. 224-232.
Anderson R. R. and J.A. Parrish (1982) Optical properties of human skin. In The science of photomedicine. Plenum Press, New York (Edited by Regan, J. D. and J.A. Parrish), pp. 174-194.
Anderson R. R., M. D. Margolis, S. Watenabe, T. Flotta, G. J. Hruza and J.S. Dover. (1989) Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532 and 355 nm. J. Invest. Dermatol., 93 28-32.
Anderson R. R. and J.A. Parrish (1983) Selective photothermolysis: precise microsurgery by selective absorption of pulses radiation. Science, 220 524-527.
Cuomo V., G. Jori, B. Rihter, M.E. Kenney and M. A. J. Rodgers (1990) Liposomes-delivered SI(IV)-naphthalocyanine as a photodynamic for experimental tumors: pharmacoikinetic and phototherapeutic studies. Br. J. Cancer 62, 966-970.
Fitzpatrick T. B., G Szabo (1959) The melanocyte : cytology and cytochemistry. J Invest Dermatol 32, 197-209.
Schuitmaker J. J., J.A van Best, J. L. van Delft, J. E. Jannink, J, A. Oosterhuis, G. F. J. M. Vrensen, D. de Wolff-Rouendaal, T. M. A. R. Dubbelman (1995) Photodynamic therapy of Hamster green melanoma in vitro using bacteriochlorin a as photosensitizer. In Photochemoterapy: Photodynamic Therapy and other modalities. SPIE vol. 2625 (Edited by Ehrenberg B., Jori G., Moan J.) pp 251-260.
Moan J., Q. Peng, V. Iani, L. Ma, R W. Horobin, K. Berg. M. Kongshang and J. M.Nesland (1995) Biodistribution, pharmacokinetic and in vivo fluorescence spectroscopic studies of photosensitizer. In Photochemotherapy: Photodynamic Therapy and other modalities. SPIE vol. 2625 (Edited by Ehrenberg B., Jori G., Moan J.) pp 234-250.
Schoenfeld N., R. Mamet, Y. Nordenberg, M. Shafran, T. Babushkin and Z. Malik. (1994). Phtoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Inc. J. Cancer, 56 106-116.
Sarna T., I. A. Menon and R. C. Sealy (1985) Photosensitization of melains: a comparative study Photochem. Photobiol. 42 529-532.
Moan J., Peng Q., Iani V., Ma L., Horobin R., Berg K. and Kongshaug M. (1996) Bidistribution, pharmocokinetic and in vivo Flourescence spectroscopic studies of photosensitizers. SPIE 2625 234-250.
Jori Giulio
Kenney Malcolm E.
Rodgers Michael A. J.
Bowling Green State University
Jones Dwayne C.
LandOfFree
Method of treatment of pigmented cancer cells utilizing photodyn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment of pigmented cancer cells utilizing photodyn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of pigmented cancer cells utilizing photodyn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2214008